In this study, we demonstrated that metformin inhibit cell growth in both ESCC and EAC cells and sensitize 5-FU cytotoxic effects by targeting CSCs and mTOR signal pathways. This evidence concerns the gene MTOR and esophageal squamous cell carcinoma.